Oct 7 (Reuters) - Mateon Therapeutics Inc MATN.PK :
* MATEON THERAPEUTICS INC - ANNOUNCED FIRST PATIENT ENROLLED THIS WEEK IN ITS PHASE IV STUDY ARTI-19
* MATEON THERAPEUTICS INC - TOP-LINE DATA FROM ARTI-19 IS EXPECTED BY END OF 4Q20
Source text for Eikon: Further company coverage: